| Literature DB >> 22303325 |
Abstract
MicroRNAs (miRNAs) are members of the small non-coding RNAs, which are principally known for their functions as post-transcriptional regulators of target genes. Regulation by miRNAs is triggered by the translational repression or degradation of their complementary target messenger RNAs (mRNAs). The growing number of reported miRNAs and the estimate that hundreds or thousands of genes are regulated by them suggest a magnificent gene regulatory network in which these molecules are embedded. Indeed, recent reports have suggested critical roles for miRNAs in various biological functions, such as cell differentiation, development, oncogenesis, and the immune responses, which are mediated by systems-wide changes in gene expression profiles. Therefore, it is essential to analyze this complex regulatory network at the transcriptome and proteome levels, which should be possible with approaches that include both high-throughput experiments and computational methodologies. Here, we introduce several systems-level approaches that have been applied to miRNA research, and discuss their potential to reveal miRNA-guided gene regulatory systems and their impacts on biological functions.Entities:
Keywords: gene regulatory network; immunoprecipitation; microRNA; proteome; systems biology; transcriptome
Year: 2011 PMID: 22303325 PMCID: PMC3268584 DOI: 10.3389/fgene.2011.00029
Source DB: PubMed Journal: Front Genet ISSN: 1664-8021 Impact factor: 4.599
Systems-level approaches to identifying miRNA functions.
| Approach | Method | Advantages | Disadvantages |
|---|---|---|---|
| Transcriptome (miRNA and target mRNA) | Microarray | Technically well developed, relatively easily applied, and cost is low | Only applicable to those with designed probes, and not capable of detecting direct target genes |
| Deep sequencing (RNA-seq) | Capable of detecting genes without probe design, suitable for detecting expression of unknown genes | Not capable of detecting direct target genes, analysis is still complicated and cost is high compared to microarray | |
| Real-time PCR array | Require only small amount of sample RNA, sensitivity and specificity is higher compared to microarray | Only applicable to those with designed TaqMan probes, and not capable of detecting direct target genes | |
| Proteome | Proteome (SILAC) | Capable of detecting miRNA targets in protein level | Sensitivity is not as high as those for transcriptome analyses, not capable of detecting direct target genes, technically still difficult to apply for most labs, and higher costs |
| IP-based approach (miRNA and target mRNA) | IP-based methods | Higher specificity, and able to detect direct interactions | Requirement of highly effective antibody, not capable of detecting targeting miRNAs, and cost is still high when using deep sequencing |
| CLIP-based methods | Higher specificity, able to detect direct interactions, and capable of detecting targeting miRNAs | Requirement of highly effective antibody, cost is still high when using deep sequencing, and technical difficulties |
Examples of studies using transcriptome analysis to identify miRNA expression.
| Method | Analyzed system | Reference | |
|---|---|---|---|
| Approach | Organism | Cell type | |
| Microarray | Human | 334 cancer samples | Lu et al. ( |
| Human | T24 cells | Saito et al. ( | |
| Human | Malignant hematopoietic cell lines | Ramkissoon et al. ( | |
| Human | Heart and skeletal muscle | Sood et al. ( | |
| Real-time PCR array | Human | Primary neuroblastoma tumor cells | Chen and Stallings ( |
| Mouse | NIT-1 cells | Bravo et al. ( | |
| Human | Primary neuroblastoma tumor cells | Chen and Stallings ( | |
| Human, mouse | MDA-MB-231 cells, CN34 cancer cells | Tavazoie et al. ( | |
| Human | Colorectal cancer (CRC) samples | Bandres et al. ( | |
| Deep sequencing | Whole organism | Lu et al. ( | |
| Deep sequencing | Human, rodent | 26 different organs and cells | Landgraf et al. ( |
| Four organisms | Whole organism | Grimson et al. ( | |
| Worm | Whole organism | Ruby et al. ( | |
| Worm | Whole organism | Friedlander et al. ( | |
| Mouse | ND13 cells | Kuchenbauer et al. ( | |
| Human | Breast cancer samples, teratoma cell lines | Nygaard et al. ( | |
| Mouse | Various tissues | Chiang et al. ( | |
| Worm | BC-3 cells (infected with KSHVb) | Umbach and Cullen ( | |
.
Figure 1Systems biology approaches to identifying miRNA targets. Flow chart describing the combined high-throughput experimental approach and computational approach for the systems-level analysis of miRNA targets. Pre-analysis using published data can be performed computationally, followed by high-throughput experimental analyses, in which the samples are prepared by overexpressing or inhibiting miRNAs in a partial population, and using the untreated population as the control. The data obtained are normalized and analyzed statistically to produce a preliminary list of genes with significantly up- or down-regulated expression. Further validation analysis is conducted to extract the biological information hidden behind the mass of data. The raw and analyzed data are distributed within databases or web services, allowing other researchers to make use of this information.
Summary of recent studies using high-throughput approaches to identify miRNA target mRNAs.
| Method | Analyzed miRNA | Analyzed system | Reference | ||||
|---|---|---|---|---|---|---|---|
| T | P | IP | Approach | miRNA | Organism | Cell type | |
| m | Overexpression | miR-1, miR-124 | Human | HeLa | Lim et al. ( | ||
| m | Inhibition | miR-122 | Mouse | Liver tissue | Krutzfeldt et al. ( | ||
| m | Inhibition | miR-30a | Human | HepG2 | Nakamoto et al. ( | ||
| m | Rescue within DICER knockout | miR-430 | Zebrafish | Embryo from Dicer mutant | Giraldez et al. ( | ||
| m | Overexpression | 24 Different miRNAs | Human | 7 Types of cells | Linsley et al. ( | ||
| m | Knockout mouse model | miR-155 | Mouse | Th1, Th2 from miR-155 KO mouse | Rodriguez et al. ( | ||
| m | Overexpression | 11 Different miRNAs | Human | HeLa | Grimson et al. ( | ||
| m | Overexpression, inhibition | miR-140 | Mouse | C3H10T1/2 | Nicolas et al. ( | ||
| d | Overexpression | miR-155 | Human | Mutu I | Xu et al. ( | ||
| m | Inhibition | miR-122 | Chimpanzee | Whole organism | Lanford et al. ( | ||
| m | Bioinformatic analysis of miRNA/mRNA expression data | Endogenous miRNAs | Human | 88 Tissues and cell types | Huang et al., | ||
| m | ○ | Bioinformatic analysis of miRNA/mRNA expression data | Endogenous miRNAs | Rat | Kidney tissue | Tian et al. ( | |
| ○ | Overexpression | miR-1 | Human | HeLa | Vinther et al. ( | ||
| m | ○ | Overexpression, KO mouse model (miR-223) | 3 Different miRNAs, miR-223 | Human, mouse | HeLa, neutrophils from miR-223 KO mouse | Baek et al. ( | |
| m | ○ | Overexpression, inhibition; pulsed SILAC method | 5 Different miRNAs | Human | HeLa | Selbach et al. ( | |
| m | ○ | IP of AGO1, AGO2 | Endogenous miRNAs | Human | HEK293T | Beitzinger et al. ( | |
| m | ○ | Overexpression (miR-1) and/or IP of AGO1 | Endogenous miRNAs, miR-1 | Fruit fly | S2 cells, miR-1 deficient fly model | Easow et al. ( | |
| m, d | ○ | IP of AIN-1, AIN-2 | Endogenous miRNAs | Worm | Whole organism | Zhang et al. ( | |
| m | ○ | Overexpression, inhibition (miR-124), IP of AGO2 | Endogenous miRNAs, miR-124 | Human, mouse | 293S, MEF, mouse cortical neurons | Karginov et al. ( | |
| m, d | ○ | Overexpression (miR-122), IP of AGO1-4, TNRC6A-C | Endogenous miRNAs, miR-122 | Human | HEK293T | Landthaler et al. ( | |
| m | ○ | Overexpression (miR-1, 124), IP of AGO2 | Endogenous miRNAs, miR-1, miR-124 | Human | HEK293T | Hendrickson et al. ( | |
| m | Overexpression (miR-1), IP of AGO1-4 | Endogenous miRNAs, miR-1 | Human | HEK293T | Hendrickson et al. ( | ||
| m | Overexpression (miR-124, miR-7), IP of AGO2 | Endogenous miRNAs, miR-124, miR-7 | Human | HEK293T | Hausser et al. ( | ||
| d | IP of AGO1-4; HITS-CLIP method | Endogenous miRNAs | Mouse | P13 mouse brain tissue | Chi et al. ( | ||
| d | IP of ALG-1; CLIP-seq method | Endogenous miRNAs | Worm | Alg-1 mutant worm model | Zisoulis et al. ( | ||
| d | IP of AGO1-4, TNRC6A-C; PAR-CLIP method | Endogenous miRNAs | Human | HEK293T | Hafner et al. ( | ||
.
Figure 2Schematic representation of SILAC labeling and proteome analysis. Cells are split and cultured in heavy or light medium containing different amino acid isotopes. The miRNAs are then overexpressed or inhibited within these cells, and the cells are incubated for several more hours. The cells are collected and their proteins are purified for further mass spectrometric analysis. The protein levels in the two samples are compared by quantifying the heavy and light peptides, because isotopic labeling will affect their migration times.
Figure 3Flow chart of the photoactivatable-ribonucleoside- enhanced cross-linking and immunoprecipitation (PAR-CLIP) methodology. PAR-CLIP analysis of miRISC component-binding RNAs. The cells are first cultured with photoreactive 4-thiouridine (4SU), which causes uridine to be incorporated during culture, and UV cross-linked to miRNP (UXL). The cross-linked miRNP–RNA complexes are immunoprecipitated using an antibody directed against miRNP, and then size fractionized by SDS-PAGE. The miRNP–RNA complexes are extracted from the gel and digested with protease. The recovered RNA molecules are converted into cDNA, where the incorporated 4-thiouridine causes T → C transitions. This transition plays a key role in the accurate mapping of the miRNP-binding sites. The cDNA library is analyzed with the deep sequencing method to determine the RNA sequences capable of interacting with miRNP.